Skip to main content
PFE
NYSE Life Sciences

Pfizer's Late-Stage Lung Cancer Drug Trial Misses Primary Endpoint

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$24.65
Mkt Cap
$142.942B
52W Low
$23.11
52W High
$28.745
52W Position info
6.7% above low
Off High info
14% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

PFE is trading near its 52-week low of $23.11 (6.7% above the low).

Summary

Pfizer's Phase 3 trial for its lung cancer drug, sigvotatug vedotin, failed to meet its primary endpoint of statistically significant improvement in overall survival for non-squamous non-small cell lung cancer. This is a setback for the company's oncology pipeline, contrasting with recent positive news regarding other drug trials and strong financial performance. While the drug showed strong efficacy in a subset of patients and a manageable safety profile, this specific indication is now in question. Pfizer continues to test the drug in a separate first-line treatment trial.

At the time of this announcement, PFE was trading at $24.65 on NYSE in the Life Sciences sector, with a market capitalization of approximately $142.9B. The 52-week trading range was $23.11 to $28.75. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

PFE - Latest Insights

PFE
Nov 16, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $29.12
Real-time Price: $28.30 info
Change: -$0.820 (-3%) info
Market Cap: $162.275B info
PFE
Nov 13, 2026, 3:19 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $28.85
Real-time Price: $28.30 info
Change: -$0.5525 (-2%) info
Market Cap: $162.275B info
PFE
Nov 11, 2026, 4:30 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $29.45
Real-time Price: $28.30 info
Change: -$1.15 (-4%) info
Market Cap: $162.275B info
PFE
Nov 03, 2026, 8:19 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.66
Real-time Price: $28.30 info
Change: -$2.36 (-8%) info
Market Cap: $162.275B info
PFE
Nov 03, 2026, 8:07 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $30.62
Real-time Price: $28.30 info
Change: -$2.32 (-8%) info
Market Cap: $162.275B info